A Multicentre Single Arm Phase II Trial Assessing the Efficacy of Immunotherapy, Chemotherapy and Stereotactic Radiotherapy to Metastases Followed by Definitive Surgery or Radiotherapy to the Primary Tumour, in Patients With Synchronous Oligo-metastatic Non-small Cell Lung Cancer. CHESS
ENSAYO CLINICO INDEPENDIENTE
Información del ensayo clínico
- Promotor: EUROPEAN THORACIC ONCOLOGY PLATFORM
- Fase: II
- Comienzo de la ejecución: 20/11/2019
- Fin de la ejecución: 30/09/2022
- IP: JAVIER VALDIVIA BAUTISTA